We are in an era of unprecedented medical innovation. Scientists are making remarkable progress to diagnose and treat diseases, bringing new hope to patients across the world. Unfortunately, these breakthroughs fail to reach everyone due to barriers to care.
The Morgan Stanley Foundation today announced its renewed commitment to hunger relief through a new $8 million, four-year pledge to Feeding America to support children’s hunger and produce programs. This grant will build on the Firm’s $13 million previous support to Feeding America, the nation’s largest domestic hunger relief charity. Since Morgan Stanley’s partnership with Feeding America launched in 2009, over 11,000 employees have volunteered more than 60,000 hours with Feeding America food banks, and over 50 million meals have been distributed.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has published its 2015 Sustainability Performance Update report.
Sandwiches are a mainstay of the American diet. Nearly half of the population eats one sandwich a day, and they welcome adventurous options to spice up their meals.
Food allergies are more common than many people think. In fact, 15 million Americans have been diagnosed with a food allergy, according to Food Allergy Research and Education (FARE), and one in three Americans report experiencing some form of negative reaction to food. Chances are someone in your office has a food allergy or intolerance.
Access to healthcare is making controversial headlines these days as the report of the High-Level Panel on Access to Medicines set up by the Secretary-General of the United Nations was just released. We need to move away from ideological disputes about intellectual property and focus on how we can help patients receive the treatments they need now.
Any solution to the access challenge needs to consider the complex factors that affect access in developing countries. It would indeed be misleading and counter-productive to focus the access debate on patents.
When Dr. Gustavo Aguirre set out to find a cure for night blindness in dogs, a disease related to Progressive Retinal Atrophy, he knew it was going to require a lot of patience. When he started studying this disease, there was no map for the canine genome. He was able to find the mutated gene that caused the disease, and, by saving his genetic samples, he made a significant contribution to the mapping of the canine genome, which was completed in 2004.
At kate spade new york and its Foundation, we believe that a woman’s mental health is foundational to her achieving sustainable long-term empowerment...
This category covers areas that aren't our signature charities. Main topics can include Homes For Our Troops as well as smaller charity organizations...
Corporate governance, risk management, operational integrity, and regulatory compliance are demanding challenges that companies face in today’s ever...
Cascale shares insights regarding policy and regulation impacting the consumer goods industry, and highlights how it's supporting members prepare for...
Cascale organizes and participates in a series of events, leveraging its position as a global convener of close to half the sector to bring together...
In states where Key has a presence, there are approximately 1.7 million low- to moderate-income (LMI) households. Many LMI individuals don’t have bank...
Entergy’s 2024 performance report, “Energy for a better future” presents an overview of our company’s 2024 achievements, future plans and strategies...
